Frontlight ResearchEarly access
Colorectal cancer trials in United States
552 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePreoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
- Where
- Houston
- Age
- 18 years and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05195710 - No phaseTaking peopleIdentifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
- Where
- Houston
- Age
- 18 years and over
- People
- 1,000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05649072 - Phase 1Taking peopleA Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Where
- Ann Arbor, Atlanta, Chicago, Duarte, Durham, Grand Rapids, Houston, Irvine, Los Angeles, Louisville, Morgantown, Nashville, New Brunswick, Oklahoma City, San Antonio, Tucson, West Valley City
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT06004245 · EU 2023-503170-20-01 - Phase 1Taking peopleA Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Where
- Atlanta, Austin, East Brunswick, Edmonds, Fairfax, Fort Worth, Grand Rapids, Houston, Lake Success, Nashville, New Brunswick, New Haven, San Antonio, Sioux Falls, St Louis, Washington D.C., West Valley City, Wilson
- Age
- 18 years and over
- People
- 124 worldwide
- Run by
- Pliant Therapeutics, Inc.
See details and how to joinNCT06270706 - No phaseTaking peoplePrecision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06878131 - No phaseTaking peopleShield Post-Approval Study Protocol
- Where
- Altoona, Anaheim, Austin, Bloomfield Township, Boca Raton, Bourbonnais, Branford, Camillus, Canoga Park, Cary, Champaign, Chandler, Chapel Hill, Chicago, Clarkston, Clifton, Conyers, Covington, Dawsonville, Delray Beach, Doral, Downers Grove, East Syracuse, Fayetteville, Garden Grove, Garland, Gilbert, Granada Hills, Hackensack, Hammond, Hillsborough, Houston, Hutchinson, Lake Barrington, Libertyville, Miami, Mocksville, Montclair, Monterey Park, Munster, New York, North Miami, Oak Lawn, Olney, Orchard Park, Palm Springs, Paris, Philadelphia, Pinehurst, Pottstown, Ridgeland, Ridgewood, Sanford, Shenandoah, Sherman Oaks, Snellville, Statesville, Tamarac, Tampa, Tarzana, Tomball, Valencia, Valley Stream, Wayne, Williamsburg, Winnetka, Woodland Hills
- Age
- 45 years to 81 years
- People
- 3,375
- Run by
- Guardant Health, Inc.
See details and how to joinNCT06880055 - Phase 2Taking peoplePhase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 90
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06959550 - Phase 3Taking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Atlanta, Baltimore, Billings, Boise, Centerville, Charlottesville, Cincinnati, Dallas, Denison, Easton, Evanston, Fairfax, Farmington, Fort Collins, Fort Myers, Fountain Valley, Hackensack, Hattiesburg, Indianapolis, Iowa City, Jacksonville, Kansas City, Las Vegas, Lexington, Lisle, Lone Tree, Los Angeles, Louisville, Milwaukee, Morgantown, New York, Ogden, Omaha, Orlando, Phoenix, Pittsburgh, Raleigh, Reno, Rochester, Sacramento, San Antonio, Santa Monica, Schenectady, Seattle, St. Petersburg, Summit, Toledo, West Palm Beach
- Age
- 18 years and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - Phase 1Taking peopleA Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Where
- Boston, Fairfax, Houston, Los Angeles, Philadelphia, Salt Lake City, San Antonio, Sarasota, Tampa
- Age
- 18 years and over
- People
- 545
- Run by
- Kestrel Therapeutics, Inc.
See details and how to joinNCT07458347 - Phase 1Taking peoplePhase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 41
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07500298 - Phase 2Taking peopleA Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Where
- Chapel Hill, Charlottesville, Cleveland, Coral Springs, East Brunswick, Fairfax, Fort Worth, Grand Rapids, Houston, Indianapolis, Los Angeles, Madison, Nashville, New York, Salt Lake City, Scottsdale, Seattle, St Louis, Tamarac, Tampa, West Valley City
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07659795 · EU 2026-526473-42-00 - Phase 3Taking peopleZanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
- Where
- Bridgewater, Council Bluffs, East Brunswick, Edison, Fort Lauderdale, Grand Island, Lake Mary, Monroe, Omaha, Orlando, Papillion, Savannah, Somerset, Toms River
- Age
- 18 years and over
- People
- 600
- Run by
- Exelixis
See details and how to joinNCT07750158 - Phase 2Taking peopleNeoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Where
- Baltimore, Boston, Chicago, Cleveland, Los Angeles, Nashville, New York, Seattle, Tampa
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Solstice Oncology, Inc.
See details and how to joinNCT07808151 · EU 2026-527233-58-00 - Phase 1/2Taking peopleA KRAS Inhibitor in Participants With Advanced Solid Tumors
- Where
- Fairfax
- Age
- 18 years and over
- People
- 320
- Run by
- Ensem Therapeutics
See details and how to joinNCT07912593 - Phase 2Taking peopleStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Boston, Grand Rapids, Houston, Los Angeles, Nashville, New Haven, Newton, Trumbull
- Age
- 18 years and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - No phaseTaking peopleRole of Diet on the Microbiome of the Digestive System
- Where
- Houston
- Age
- 45 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04666727 - Phase 1/2Taking peopleA Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Where
- Ann Arbor, Baltimore, Boston, Charlottesville, Fairfax, Houston, Los Angeles, Nashville, New York, Philadelphia, Salt Lake City, Seattle, St Louis
- Age
- 18 years and over
- People
- 616 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07020221 - Phase 1Taking peopleA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Where
- Austin, Celebration, Denver, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Irvine, Irving, Lake Success, Nashville, New Haven, New York, Plantation, San Antonio, Sarasota, Spokane, West Valley City
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07503808 · EU 2026-526299-21-00 - No phaseNot yet taking people in United StatesSymptomatic FIT for Colon Cancer Detection, a Pilot Study
- Where
- La Jolla
- Age
- 18 years and over
- People
- 40
- Run by
- University of California, San Diego
See details and how to joinNCT07927270 - No phaseNot yet taking people in United StatesSCREEN Yourself for Cancer
- Where
- Hershey
- Age
- 30 years to 75 years
- People
- 852
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT07927686 - No phaseTaking peopleCollection of Blood From Patients With Cancer
- Where
- Bethesda
- Age
- 18 years and over
- People
- 1,750
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00034216 - No phaseTaking peopleFollow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- Where
- Bethesda
- Age
- 18 years and over
- People
- 750
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00451022 - Phase 1Taking peopleMetarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Where
- Bethesda, Fairway
- Age
- 12 years to 120 years
- People
- 116
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04222413 - Phase 1Taking peopleTesting the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Where
- Aurora, Charlottesville, Columbus, Costa Mesa, Fairway, Houston, Irvine, Kansas City, Los Angeles, New Orleans, Oklahoma City, Orange, Overland Park, Richmond, Westwood
- Age
- 18 years and over
- People
- 30
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06102902 - Phase 1/2Taking peoplePhase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06149481